A new "fluid biopsy" technique which identifies specific cells as markers in the bloodstream has been developed to predict early onset of heart attacks.
The technique developed by a group of researchers at the Scripps Research Institute will help identify patients at high risk of a heart attack by identifying circulating endothelial cells.
It has been successful in distinguishing patients undergoing treatment for a recent heart attack with a healthy control group and can now be tested on patients who exhibit symptoms but are yet to experience a heart attack.
Peter Kuhn, who led the study, said that the goal of the paper was to establish evidence that these circulating endothelial cells can be detected reliably in patients following a heart attack and do not exist in healthy controls.
Currently, there is no predictive test for a heart attack which is accurate.
The technique has been described in the latest edition of IOP Publishing's journal Physical Biology.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
